October 9, 2026

Theravance Biopharma (TBPH) Stock Analysis: Evaluating the Potential with a 3.74% Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a key player in the healthcare sector, is carving its niche within the biotechnology industry. With a market capitalization of $884.18..

Verastem, Inc. (VSTM) Stock Analysis: Unpacking the 85% Potential Upside

Verastem, Inc. (NASDAQ: VSTM) has been capturing investor attention with its promising biopharmaceutical innovations and the potential for significant stock appreciation. As a development-stage biotechnology company,..

Oruka Therapeutics, Inc. (ORKA)

⚠️ No article content returned.

..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating Growth Amidst Market Challenges

Fortrea Holdings Inc. (NASDAQ: FTRE) stands as a notable entity within the biotechnology industry, offering a spectrum of development solutions for biopharmaceutical products and medical devices...

Tyra Biosciences (TYRA) Stock Analysis: Unveiling a 137% Upside Potential in the Biotechnology Sector

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology firm focused on developing precision medicines targeting fibroblast growth factor receptor (FGFR) biology, presents an intriguing opportunity for..

Abivax SA (ABVX) Stock Analysis: Potential 84% Upside with Strong Buy Ratings and Promising Drug Pipeline

For investors seeking opportunities in the biotechnology sector, Abivax SA (ABVX) presents a compelling case with its significant upside potential and a unanimous positive outlook from..

Altimmune, Inc. (ALT) Stock Analysis: A Potential 558% Upside in the Biotech Sector

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is currently making waves in the healthcare sector with its focus on innovative therapies for serious liver diseases...

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Navigating the 56.25% Upside Potential

Investors eyeing opportunities in the healthcare sector may find Organogenesis Holdings Inc. (NASDAQ: ORGO) an intriguing prospect, especially given its potential upside of 56.25% based on..

MBX Biosciences, Inc. (MBX) Investor Outlook: 77% Potential Upside as Phase 3 Trials Advance

MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company, is capturing investor attention with a promising 77.09% potential upside, according to the latest analyst ratings. This..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: A 41.94% Potential Upside in the Medical Devices Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI) is garnering attention within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $252.01 million,..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 38.69% Potential Upside in the Medical Device Market

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector specializing in medical devices, has captured the attention of investors with its potential for substantial..

Celcuity Inc. (CELC) Stock Analysis: A Biotech Gem with 131% Upside Potential

Celcuity Inc. (NASDAQ: CELC) is gaining significant attention in the biotechnology sector, not just for its cutting-edge research in cancer therapies but also for its promising..

InnovAge Holding Corp. (INNV) Stock Analysis: A Closer Look at Growth Potential Amidst Market Fluctuations

InnovAge Holding Corp. (NASDAQ: INNV) is a player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.24 billion,..

Upstream Bio, Inc. (UPB) Stock Analysis: A 584.46% Upside Potential in the Biotech Space

Upstream Bio, Inc. (UPB), a clinical-stage biotechnology company, has caught the attention of investors with a staggering potential upside of 584.46%, according to the latest analyst..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 202% Upside

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering entity in the biotechnology sector, has recently caught the attention of investors due to its promising potential for substantial..

Claritev Corporation (CTEV) Stock Analysis: Exploring an 89% Upside Potential

Investors with an eye on the healthcare sector may find Claritev Corporation (CTEV) particularly intriguing, especially given its impressive potential upside of 89.07%. Operating within the..

SIGA Technologies Inc. (SIGA) Stock Analysis: Insight into Current Challenges and Opportunities

Investors eyeing SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector, are met with a mixed bag of financial metrics that warrant a..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Navigating Biotech’s Potential with a 38.94% Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology innovator, is capturing the attention of investors with its cutting-edge approach to developing antibody-based medicines. Despite the recent..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 541% Potential Upside Amidst Biotech Advances

Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of investors, not just for its innovative approach in the biotech sector, but also for its eye-catching potential..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Exploring a 37.65% Potential Upside

Sonida Senior Living, Inc. (SNDA) is a prominent player in the healthcare sector, focusing on medical care facilities specifically tailored for senior housing communities in the..

Search

Funds

October 9, 2026

Search

Funds

October 9, 2026

FTSE 100

Funds